Linda R. Duska, MD

University of Virginia

DuskaDr. Duska is Associate Professor and Gynecologic Oncology Fellowship Director at the University of Virginia in Charlottesville VA.  Dr. Duska holds multiple leadership roles both at UVA and nationally, including serving as the Foundation for Women’s Cancers Board of Directors and Advocacy Group Chair, co-Chair of the SGO Program Director Committee, and Chair of the SGO Program Development sub-committee.  She has a special interest in hormonal treatment of endometrial cancer, and has written multiple book chapters and peer review articles on this subject.

She completed her Fellowship in Gynecologic Oncology at the Massachusetts General Hospital in Boston.  She received the Gynecologic Cancer Foundation/GSK award in 2004 for her project entitled “Testing the significance of Cables expression in identification and genes of endometrial cancer” in 2004 while working in Boston at the MGH.  She is a full member of several organizations, including the SGO, ASCO and AGOS.  She is active in GOG, having served as a past member of the GOG’s corpus committee and as a current member of the Developmental Therapeutics and Phase I committees.  Dr. Duska’s current research focus is on translational aspects of clinical trials, and she is currently the PI of a multi-institutional investigator initiated study in ovarian cancer

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.